Novo Holdings A/S’s Rocket Pharmaceuticals RCKT Stock Holding History

Novo Holdings A/S’s Portfolio RCKT Stock Details RCKT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,100,000	Closed	-$7.34M	–	32
2025 Q1	$7.34M	Hold	1,100,000	–	–	0.56%	23
2024 Q4	$13.8M	Hold	1,100,000	–	–	0.84%	23
2024 Q3	$20.3M	Hold	1,100,000	–	–	1.01%	25
2024 Q2	$23.7M	Buy	1,100,000 +50,000	+5%	+$1.15M	1.28%	27
2024 Q1	$28.3M	Hold	1,050,000	–	–	1.95%	18
2023 Q4	$31.5M	Buy	1,050,000 +49,000	+5%	+$1.08M	1.94%	20
2023 Q3	$20.5M	Buy	1,001,000 +81,000	+9%	+$1.47M	1.52%	26
2023 Q2	$18.3M	Hold	920,000	–	–	1.41%	25
2023 Q1	$15.8M	Buy	920,000 +70,000	+8%	+$1.37M	1.04%	28
2022 Q4	$16.6M	Buy	850,000 +217,178	+34%	+$4M	1.04%	25
2022 Q3	$10.1M	Hold	632,822	–	–	0.48%	37
2022 Q2	$8.71M	Buy	632,822 +20,000	+3%	+$238K	0.43%	41
2022 Q1	$9.72M	Hold	612,822	–	–	0.51%	34
2021 Q4	$13.4M	Buy	612,822 +78,737	+15%	+$2.15M	0.63%	27
2021 Q3	$16M	Buy	+534,085	New	+$19.4M	0.83%	26

Other funds holding RCKT

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.6B AUM 48.76% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return